PatientsVille.com Logo

PatientsVille

Telfast Side Effects

Common Telfast Side Effects


The most commonly reported Telfast side effects (click to view or check a box to report):

Dizziness (9)
Tachycardia (8)
Tremor (6)
Spleen Disorder (5)
Bradycardia (5)
Nausea (5)
Unevaluable Event (5)
Toxic Skin Eruption (4)
Liver Disorder (4)
Hallucination (4)
Syncope (4)
Dry Mouth (4)
Balance Disorder (4)
Chondrolysis (4)
Rash (3)
Asthenia (3)
Off Label Use (3)
Lymphadenopathy (3)
Convulsion (3)
Nervousness (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Telfast Side Effects Reported to FDA

The following Telfast reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Telfast on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Suicidal Ideation
This is a report of a 99-year-old male patient (weight: NA) from AU, suffering from the following symptoms/conditions: NA, who was treated with Telfast (dosage: NA, start time: NS), combined with:
  • Efexor
and developed a serious reaction and side effect(s). The consumer presented with:
  • Suicidal Ideation
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Telfast treatment in male patients, resulting in suicidal ideation side effect.

Dry Mouth, Dyspnoea
This report suggests a potential Telfast Dry Mouth, Dyspnoea side effect(s) that can have serious consequences. A 50-year-old male patient (weight: NA) from IL was diagnosed with the following symptoms/conditions: hypersensitivity and used Telfast (dosage: NA) starting NS. Soon after starting Telfast the patient began experiencing various side effects, including:
  • Dry Mouth
  • Dyspnoea
Drugs used concurrently: NA.The patient was hospitalized. Although Telfast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as dry mouth, may still occur.

Bronchospasm, Wheezing, Cough, Chest Discomfort
This Bronchospasm, Wheezing, Cough, Chest Discomfort problem was reported by a consumer or non-health professional from GB. A 24-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: seasonal allergy. On NS this consumer started treatment with Telfast (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Telfast, the patient experienced the following unwanted symptoms/side effects:
  • Bronchospasm
  • Wheezing
  • Cough
  • Chest Discomfort
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as bronchospasm, may become evident only after a product is in use by the general population.

Guillain-barre Syndrome, Coordination Abnormal, Gait Disturbance, Muscle Contractions Involuntary, Tremor, Dystonia, Extrapyramidal Disorder, Parkinson^s Disease, Neuropathy Peripheral
This is a report of a 55-year-old male patient (weight: NA) from AU. The patient developed the following symptoms/conditions: sinus disorder,hypertension and was treated with Telfast (dosage: NA) starting Aug 01, 2000. Concurrently used drugs:
  • Micardis
  • Dapa-tabs
Soon after that, the consumer experienced the following side effects:
  • Guillain-barre Syndrome
  • Coordination Abnormal
  • Gait Disturbance
  • Muscle Contractions Involuntary
  • Tremor
  • Dystonia
  • Extrapyramidal Disorder
  • Parkinson^s Disease
  • Neuropathy Peripheral
This opens a possibility that Telfast treatment could cause the above reactions, including guillain-barre syndrome, and some male subjects may be more susceptible.


Anxiety, Extrapyramidal Disorder, Serotonin Syndrome, Akathisia, Dyskinesia, Dystonia, Hostility, Tremor
A 30-year-old male patient (weight: NA) from NL with the following symptoms/conditions: alpha-1 anti-trypsin deficiency,attention deficit/hyperactivity disorder started Telfast treatment (dosage: NA) on 200811. Soon after starting Telfast treatment, the subject experienced various side effects, including:
  • Anxiety
  • Extrapyramidal Disorder
  • Serotonin Syndrome
  • Akathisia
  • Dyskinesia
  • Dystonia
  • Hostility
  • Tremor
Concurrently used drugs:
  • Efexor Xr (Strength: 37.5 Mg)
This finding indicates that some male patients could be more vulnerable to Telfast.

Activities Of Daily Living Impaired, Asthma, Dyspnoea, Chest Discomfort, Therapeutic Response Decreased, Appetite Disorder, Rash, Pruritus, Insomnia
A 35-year-old male patient from GB (weight: NA) experienced symptoms, such as: seasonal allergy,gastrooesophageal reflux disease,asthma and was treated with Telfast(dosage: NA). The treatment was initiated on Jul 01, 2013. After that a consumer reported the following side effect(s):
  • Activities Of Daily Living Impaired
  • Asthma
  • Dyspnoea
  • Chest Discomfort
  • Therapeutic Response Decreased
  • Appetite Disorder
  • Rash
  • Pruritus
  • Insomnia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Telfast efficacy:
  • Omeprazole
  • Symbicort (Dose: 400 Mcg 1 Puff Twice A Day)
The patient was hospitalized and became disabled.

Acute Pulmonary Oedema, Myocardial Infarction
In this report, Telfast was administered for the following condition: NA.A 37-year-old male consumer from FR (weight: NA) started Telfast treatment (dosage: NA) on Jul 17, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Acute Pulmonary Oedema
  • Myocardial Infarction
A possible interaction with other drugs could have contributed to this reaction:
  • Tercian (Dose:1 Unit(s))
  • Tercian (Dose:2 Unit(s))
  • Tercian
  • Seretide (Route: Respiratory)
  • Lexomil
  • Laroxyl
  • Laroxyl (Dose:1 Unit(s))
  • Amisulpride
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Telfast treatment could be related to the listed above side effect(s).

Exposure During Pregnancy
This is a report of the following Telfast side effect(s):
  • Exposure During Pregnancy
A 37-year-old female patient from CH (weight: NA) presented with the following condition: urticaria and received a treatment with Telfast (dosage: NA) starting: Mar 01, 2013.The following concurrently used drugs could have generated interactions:
  • Atarax
  • Cetallerg
  • Biotin
  • Ranitidine Hydrochloride
  • Passiflora Incarnata Flower
This report suggests that a Telfast treatment could be associated with the listed above side effect(s).

Toxic Skin Eruption
This Telfast report was submitted by a 47-year-old female consumer from FR (weight: NA). The patient was diagnosed with: eczema and Telfast was administered (dosage: NA) starting: Feb 05, 2013. The consumer developed a set of symptoms:
  • Toxic Skin Eruption
Other drugs used simultaneously:
  • Atarax
  • Copper Sulfate/zinc Oxide
  • Diprosone
  • Aerius
  • Pevisone
The patient was hospitalized.Those unexpected symptoms could be linked to a Telfast treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Tachycardia, Palpitations, Dyspnoea, Nervousness
This is a report of a possible correlation between Telfast use and the following symptoms/side effect(s):
  • Tachycardia
  • Palpitations
  • Dyspnoea
  • Nervousness
which could contribute to an assessment of Telfast risk profile.A 40-year-old female consumer from IE (weight: NA) was suffering from nasal congestion and was treated with Telfast (dosage: NA) starting Jan 02, 2013.Other concurrent medications: NA.

Local Swelling
A 38-year-old female patient from SG (weight: NA) presented with the following symptoms: NA and after a treatment with Telfast (dosage: NA) experienced the following side effect(s):
  • Local Swelling
The treatment was started on NS. Telfast was used in combination with the following drugs: NA.This report could alert potential Telfast consumers.

Hepatotoxicity
In this report, a 65-year-old female patient from DE (weight: NA) was affected by a possible Telfast side effect.The patient was diagnosed with urticaria. After a treatment with Telfast (dosage: NA, start date: Dec 04, 2012), the patient experienced the following side effect(s):
  • Hepatotoxicity
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Telfast treatment.

Face Oedema, Eye Swelling
This is a report of a 78-year-old female patient from SG (weight: NA), who used Telfast (dosage: NA) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Face Oedema
  • Eye Swelling
The following drugs could possibly have interacted with the Telfast treatment NA.Taken together, these observations suggest that a Telfast treatment could be related to side effect(s), such as Face Oedema, Eye Swelling.

Paraesthesia, Pain, Muscular Weakness
This paraesthesia side effect was reported by a physician from GB. A 59-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Telfast (dosage: NA), which was started on 2006. Concurrently used drugs:
  • Omeprazole
  • Folic Acid
  • Adcal-d3 (750 Mg And 5 Mcg)
  • Prednisolone (5 Mg Once Every Other Day)
  • Crotamiton
  • Candesartan Cilexetil
  • Darbepoetin Alfa (Every Fortnight)
  • Diprobase Cream
When starting to take Telfast the consumer reported the following symptoms:
  • Paraesthesia
  • Pain
  • Muscular Weakness
The patient was hospitalized. These side effects may potentially be related to Telfast.

Ventricular Arrhythmia, Electrocardiogram Qt Prolonged
This is a Telfast side effect report of a 45-year-old male patient (weight:NA) from PL, suffering from the following symptoms/conditions: neuropathic pain, who was treated with Telfast (dosage:NA, start time: Jun 10, 2012), combined with:
  • Methadone Hydrochloride
  • Amitriptyline
  • Depakine
  • Gabapentin
  • Prestarium
  • Indapen
  • Lidocaine
, and developed a serious reaction and a ventricular arrhythmia side effect. The patient presented with:
  • Ventricular Arrhythmia
  • Electrocardiogram Qt Prolonged
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Telfast treatment in male patients suffering from neuropathic pain, resulting in ventricular arrhythmia.

Suicidal Ideation, Depressive Symptom
This report suggests a potential Telfast suicidal ideation side effect(s) that can have serious consequences. A 54-year-old female patient from NO (weight:NA) was diagnosed with the following health condition(s): NA and used Telfast (dosage: NA) starting NS. Soon after starting Telfast the patient began experiencing various side effects, including:
  • Suicidal Ideation
  • Depressive Symptom
Drugs used concurrently:NA. Although Telfast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as suicidal ideation, may still occur.

Systemic Lupus Erythematosus, Paraesthesia, Urge Incontinence, No Therapeutic Response, Auricular Perichondritis
This systemic lupus erythematosus problem was reported by a pharmacist from DENMARK. A 44-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Jan 01, 2005 a consumer started treatment with Telfast (fexofenadine (120 Milligram) (fexofenadine) (dosage: NA). The following drugs/medications were being taken at the same time:
  • Tramadol (tramadol) (100 Milligram) (tramadol)
  • Escitalopram Oxalate (10 Mg (10 Mg, 1 In 1 D), Oral)
  • Ranitidin (ranitidine Hydrochloride) (ranitidine Hydorchloride)
  • Escitalopram Oxalate (20 Mg (20 Mg, 1 In 1 D), Oral)
  • Pentatop (cromoglicate Sodium) (200 Milligram) (cromoglicate Sodium)
  • L-thyroxin (levothyroxine Sodium) (88 Microgram) (levothyroxine Sodium
When commencing Telfast (fexofenadine (120 Milligram) (fexofenadine), the patient experienced the following unwanted symptoms /side effects:
  • Systemic Lupus Erythematosus
  • Paraesthesia
  • Urge Incontinence
  • No Therapeutic Response
  • Auricular Perichondritis
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as systemic lupus erythematosus, may become evident only after a product is in use by the general population.

Asthma, Cerebral Haemorrhage
This is a Telfast (germany) side effect report of a female patient (weight: NA) from SWITZERLAND. The patient developed the following symptoms/conditions: NA and was treated with Telfast (germany) (dosage: NA) starting Feb 01, 2007. Concurrently used drugs:
  • Viani (Unk)
  • Xolair (375 Mg, Q2w)
  • Albuterol Sulfate
Soon after that, the consumer experienced the following of symptoms:
  • Asthma
  • Cerebral Haemorrhage
The patient was hospitalized. This opens a possibility that Telfast (germany) could cause asthma and that some female patients may be more susceptible.

Vasculitis Cerebral
A 53-year-old female patient (weight: NA) from AUSTRALIA with the following symptoms: sinusitis,spondylitis,herpes zoster started Telfast treatment (dosage: NA) on Jan 01, 2005. Soon after starting Telfast treatment, the consumer experienced several side effects, including:
  • Vasculitis Cerebral
. Concurrently used drugs:
  • Humira
  • Doxycycline
  • Famvir
  • Panadol
  • Seretide
  • Panadol
  • Thyroxin
  • Remifemin
This finding indicates that some patients can be more vulnerable to developing Telfast side effects, such as vasculitis cerebral.

Hallucination
This hallucination side effect was reported by a health professional from ISRAEL. A 23-year-old male patient (weight:NA) experienced the following symptoms/conditions: rash.The patient was prescribed Telfast (dosage: NA), which was started on NS. Concurrently used drugs: NA..When starting to take Telfast the consumer reported symptoms, such as:
  • Hallucination
These side effects may potentially be related to Telfast.

Hallucination
This is a report of a 23-year-old male patient (weight: NA) from ISRAEL, suffering from the following symptoms/conditions: NA, who was treated with Telfast (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Hallucination
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Telfast treatment in male patients, resulting in hallucination side effect.

Visual Impairment, Libido Decreased, Memory Impairment, Spleen Disorder, Diabetes Mellitus, Performance Status Decreased, Unevaluable Event, Blood Pressure Increased, Chondrolysis
This report suggests a potential Telfast Visual Impairment, Libido Decreased, Memory Impairment, Spleen Disorder, Diabetes Mellitus, Performance Status Decreased, Unevaluable Event, Blood Pressure Increased, Chondrolysis side effect(s) that can have serious consequences. A male patient (weight: NA) from GERMANY was diagnosed with the following symptoms/conditions: NA and used Telfast (dosage: NA) starting Oct 11, 2004. Soon after starting Telfast the patient began experiencing various side effects, including:
  • Visual Impairment
  • Libido Decreased
  • Memory Impairment
  • Spleen Disorder
  • Diabetes Mellitus
  • Performance Status Decreased
  • Unevaluable Event
  • Blood Pressure Increased
  • Chondrolysis
Drugs used concurrently:
  • Diclofenac
  • Antihypertensives
  • Ibuprofen
  • Cholesterol- And Triglyceride Reducers
Although Telfast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as visual impairment, may still occur.

Diabetes Mellitus, Spleen Disorder, Unevaluable Event, Chondrolysis, Liver Disorder, Metabolic Disorder
This Diabetes Mellitus, Spleen Disorder, Unevaluable Event, Chondrolysis, Liver Disorder, Metabolic Disorder problem was reported by a physician from GERMANY. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Oct 11, 2004 this consumer started treatment with Telfast (dosage: NA). The following drugs were being taken at the same time:
  • Antihypertensives
  • Diclofenac
  • Cholesterol- And Triglyceride Reducers
  • Ibuprofen
When commencing Telfast, the patient experienced the following unwanted symptoms/side effects:
  • Diabetes Mellitus
  • Spleen Disorder
  • Unevaluable Event
  • Chondrolysis
  • Liver Disorder
  • Metabolic Disorder
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as diabetes mellitus, may become evident only after a product is in use by the general population.

Chondrolysis, Diabetes Mellitus, Liver Disorder, Spleen Disorder, Unevaluable Event
This is a report of a male patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Telfast (dosage: NA) starting Oct 11, 2004. Concurrently used drugs:
  • Antihypertensives
  • Cholesterol- And Triglyceride Reducers
  • Ibuprofen
  • Diclofenac
Soon after that, the consumer experienced the following side effects:
  • Chondrolysis
  • Diabetes Mellitus
  • Liver Disorder
  • Spleen Disorder
  • Unevaluable Event
This opens a possibility that Telfast treatment could cause the above reactions, including chondrolysis, and some male subjects may be more susceptible.

Chondrolysis, Liver Disorder, Spleen Disorder, Unevaluable Event
A male patient (weight: NA) from GERMANY with the following symptoms/conditions: NA started Telfast treatment (dosage: NA) on Oct 11, 2004. Soon after starting Telfast treatment, the subject experienced various side effects, including:
  • Chondrolysis
  • Liver Disorder
  • Spleen Disorder
  • Unevaluable Event
Concurrently used drugs:
  • Antihypertensives
  • Cholesterol- And Triglyceride Reducers
  • Ibuprofen
  • Diclofenac
This finding indicates that some male patients could be more vulnerable to Telfast.

1 of 5 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Telfast Side Effects

    Did You Have a Telfast Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Telfast for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective